Emerging human research explores Bergamonte® polyphenols for cognitive and executive performance, supported by a broader scientific foundation in vascular health, metabolic balance, antioxidant defense, and cellular maintenance.
Cognition represents an emerging extension of the Bergamonte® research platform. Preliminary human research provides a direct starting point, while the ingredient’s established work in vascular health, metabolic balance, antioxidant defense, and cellular maintenance creates a broader rationale for its use in cognitive and healthy-aging formulations.
Human Cognitive Research
An eight-week pilot study evaluated cognitive and executive performance using established neuropsychological assessments.
Polyphenol-Rich Botanical Platform
Provides a defined spectrum of flavonoids with broader metabolic and antioxidant research.
Healthy-Aging Crossover
Naturally connects cognition with vascular, metabolic, and cellular wellness.
Differentiated Formula Potential
Offers product developers an alternative to conventional stimulant-heavy cognitive ingredients.
Bergamonte® is best known for cardiometabolic research, but published human data have also begun to explore the relationship between bergamot polyphenols and cognitive performance. An eight-week pilot study evaluated several dimensions of executive function and verbal performance, while the wider bergamot research portfolio provides additional context through antioxidant, metabolic, and cellular-maintenance pathways. The cognition evidence is promising but should be positioned as an emerging area of research.
Key Clinical Benefits
An eight-week open-label pilot study evaluated cognitive performance following supplementation with Bergamot Polyphenolic Fraction using established neuropsychological assessments. Significant changes were reported in selected measures, providing preliminary human evidence for this emerging application of bergamot polyphenols.
Executive function includes abilities such as cognitive flexibility, attention, and the capacity to shift strategies when circumstances change. The pilot study reported significant improvements in WCST perseverative errors and semantic fluency, offering a more specific scientific basis for executive-performance positioning.
Healthy cognitive aging is influenced by vascular function, metabolic health, oxidative balance, and normal cellular maintenance. Bergamonte® has substantial research across these supporting systems, although the current evidence should not be interpreted as a clinical demonstration of preventing age-related cognitive decline.
An 8-week open-label pilot study evaluated BPF supplementation in 20 adults receiving second-generation antipsychotics, using established tests of executive function, verbal fluency and cognitive processing. Significant changes were reported in two cognitive measures, providing preliminary human evidence for further investigation of BPF and cognitive function.*
Twenty participants received 1,000 mg/day BPF for eight weeks and completed the Wisconsin Card Sorting Test before and after supplementation. At week 8, researchers reported a significant improvement in WCST perseverative errors, an endpoint related to cognitive flexibility and executive functioning (p = 0.004).
The same 8-week study also evaluated verbal fluency. Semantic fluency significantly improved at week 8 (p = 0.004), while phonemic fluency and several other cognitive measures showed favorable trends that did not reach the same reported significance threshold.
Why it matters: A second significant finding was observed in semantic verbal fluency.
Findings are from a small, 8-week open-label pilot study in 20 adults with schizophrenia receiving second-generation antipsychotics. Results are preliminary and should not be generalized to healthy populations. Additional controlled clinical research is needed.
Cognitive health does not exist independently from the rest of the body. Healthy circulation helps deliver oxygen and nutrients to the brain, metabolic health influences energy availability, and antioxidant and cellular-defense systems help maintain a healthy neurological environment over time. These connections are increasingly relevant as cognitive wellness becomes part of the broader healthy-aging conversation.
Bergamonte® offers an emerging opportunity within this space. Its direct cognition evidence is currently more limited than its cardiovascular research, but preliminary human findings can be supported by a much broader body of research in metabolic, vascular, antioxidant, and cellular pathways. This makes careful, evidence-led positioning especially important.
Bergamonte® brings a distinct non-stimulant, polyphenol-based approach to cognition, supported by preliminary human research and a broader foundation in metabolic and vascular science.
Cognition has a narrower ingredient fit than the other benefit areas because the human evidence comes from a small exploratory study conducted specifically with Bergamot Polyphenolic Fraction. For that reason, this section should stay focused rather than extending the research broadly across unrelated Bergamonte® products.
let’s get started
Discuss your formulation goals, intended positioning, research needs, and product-development opportunities with the HP Ingredients team.
Schedule Now
Evaluate Bergamonte® for your next product concept with a sample for formulation, compatibility, and product-development testing.
Request Now
Ready to explore how Bergamonte® can support your product pipeline? Contact HP Ingredients for samples, technical documentation, clinical research, formulation guidance, and next-step support.
Contact Us